| 摘要 |
The invention relates to compounds of the formula Ris selected from the group consisting of hydrogen, linear C-Calkyl and fluorinated linear C-Calkyl; Ris hydrogen or methyl; Ris selected from the group consisting of hydrogen, halogen, C-C-alkyl, fluorinated C-C-alkyl, C-C-alkoxy and fluorinated C-C-alkoxy, Ris C-C-alkyl or fluorinated C-C-alkyl; n is 0, 1 or 2, and the physiologically tolerated salts of these compounds and the N-oxides thereof. The invention also relates to a pharmaceutical composition that comprises at least one compound of the formula I and/or at least one physiologically tolerated acid addition salt thereof, and further to a method for treating disorders that respond beneficially to dopamine Dreceptor antagonists or dopamine Dagonists, said method comprising administering an effective amount of at least one compound or physiologically tolerated acid addition salt of the formula I to a subject in need thereof.
|
